$SWIM

CFO Corner: Oliver Gloe, Latham Group

Latham Group Inc. CFO Oliver Gloe discusses the company's growth strategy, AI adoption, and navigating market cycles. The pool maker expects 12% growth in 2023 despite a flat industry, driven by disciplined cost management and strategic investments. Gloe highlights the importance of a business-partnering mindset in the finance team and the early adoption of AI for data analysis and forecasting. Latham Group is listed on Nasdaq under the ticker 'SWIM'.

Original reporting
Published Oct 9, 2026, 6:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 8:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
CFO Corner: Oliver Gloe, Latham Group — source image
Decision brief

The 30-second read

$SWIMBullishLow
01

Why it matters

The 12% growth guidance is the key new data point that could influence the stock's valuation.

02

Market read

Fresh guidance may attract interest from investors tracking consumer discretionary and cyclical stocks.

03

What to watch

Potential impact of rising interest rates on financed customers could dampen demand.

Relevance 6/10Novelty 6/10Timing: guidance applies to the current fiscal year

Background

The interview provides insight into Latham Group's post‑downturn stabilization and its shift to expansion mode.

Company-level read

Ticker impact

$SWIMBullishMedium confidence
Context

CFO Oliver Gloe disclosed that Latham Group targets 12% revenue growth for the year, marking fresh guidance from the company.

Expected impact

upward pressure as investors price in stronger growth outlook

Evidence & confidence

The new 12% growth guidance is a primary disclosure that could lift sentiment, but the magnitude is modest and the sector is cyclical.

Market effects

Higher growth outlook may benefit other pool and home‑improvement related stocks.

North American consumer discretionary sentiment could improve.

Limited, as the company operates primarily in NA, AU and NZ.

Counterpoint

If consumer financing tightens, the growth target may be overly optimistic.

Key entities

  • Latham Group Inc.

    Designer and manufacturer of residential swimming pools, listed on Nasdaq under SWIM.

  • Oliver Gloe

    Chief Financial Officer of Latham Group.

Related articles

Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

$FULCMedAI 8/10

Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

$SWIMMedAI 8/10

Latham Group (SWIM) Q2 2026 Earnings Call Transcript

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

$LOGCMedAI 8/10

Latham Represents Blackstone Credit & Insurance in Financing for ContextLogic’s Acquisition of gChem for US$850 Million

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.